These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24088504)

  • 1. Use of hydroxyethyl starch in critically ill patients.
    Bugedo G; Romero C
    Crit Care; 2013 Oct; 17(5):455. PubMed ID: 24088504
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-centered outcomes and trials of hydroxyethyl starch.
    Myburgh J; Finfer S; Bellomo R
    Crit Care; 2013 Sep; 17(5):452. PubMed ID: 24073610
    [No Abstract]   [Full Text] [Related]  

  • 3. Existing trial data do not support that hydroxyethyl starch is less harmful when given on more 'correct' indications.
    Haase N; Müller RG; Perner A
    Crit Care; 2013 Nov; 17(6):461. PubMed ID: 24229437
    [No Abstract]   [Full Text] [Related]  

  • 4. Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement.
    Meybohm P; Van Aken H; De Gasperi A; De Hert S; Della Rocca G; Girbes AR; Gombotz H; Guidet B; Hasibeder W; Hollmann MW; Ince C; Jacob M; Kranke P; Kozek-Langenecker S; Loer SA; Martin C; Siegemund M; Wunder C; Zacharowski K
    Crit Care; 2013 Jul; 17(4):R166. PubMed ID: 23890518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.
    Zarychanski R; Abou-Setta AM; Turgeon AF; Houston BL; McIntyre L; Marshall JC; Fergusson DA
    JAMA; 2013 Feb; 309(7):678-88. PubMed ID: 23423413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch for resuscitation.
    Haase N; Perner A
    Curr Opin Crit Care; 2013 Aug; 19(4):321-5. PubMed ID: 23743591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyethyl starch in critically ill patients.
    Brunkhorst FM; Schortgen F
    Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265
    [No Abstract]   [Full Text] [Related]  

  • 8. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients.
    Mayor S
    BMJ; 2013 Oct; 347():f6197. PubMed ID: 24126958
    [No Abstract]   [Full Text] [Related]  

  • 9. NHS should ban use of starch based intravenous fluids, say researchers.
    Wise J
    BMJ; 2013 Feb; 346():f1323. PubMed ID: 23447423
    [No Abstract]   [Full Text] [Related]  

  • 10. Infusion of hydroxyethyl starch-containing fluids.
    Aubron C; Bellomo R
    Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
    Perel P; Roberts I; Ker K
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000567. PubMed ID: 23450531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis.
    Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
    Anesth Analg; 2012 Jan; 114(1):159-69. PubMed ID: 22184610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACP Journal Club. Review: hydroxyethyl starch increases mortality and acute kidney injury in critically ill patients.
    Myburgh J
    Ann Intern Med; 2013 Jun; 158(12):JC4. PubMed ID: 23778928
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.
    Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
    Intensive Care Med; 2013 Apr; 39(4):558-68. PubMed ID: 23407978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement.
    Cruickshanks M; Drummond GB; Paterson-Brown S; Powell AG
    BMJ; 2013 Jul; 347():f4651. PubMed ID: 23900815
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
    Mills GH
    Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous starches: is suspension the best solution?
    Raghunathan K; Miller TE; Shaw AD
    Anesth Analg; 2014 Sep; 119(3):731-736. PubMed ID: 25137004
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluids in acute respiratory distress syndrome: pros and cons.
    Silva PL; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):104-12. PubMed ID: 24345852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.